Search bioRxiv⌕ Search

Biology subjects

Nassr, T.

Publications and source records attributed to Nassr, T..

2 recordsLinked to original sources

The transcription factor SiROCX controls a monocot-specific CAZyme program for host cell wall remodeling during symbiotic root colonization

Intracellular accommodation of beneficial fungi requires controlled remodeling of host cell walls while avoiding activation of plant immune responses. During colonization of monocot roots, the endophytic fungus Serendipita indica induces a suite of carbohydrate-active enzymes (CAZymes) targeting xylan and cellulose. Weighted gene co-expression network analysis identified the basidiomycete-specific transcription factor SiROCX as a key regulator of this monocot-adapted program. DNA affinity purification sequencing (DAP-seq) defined the SiROCX binding motif and revealed a CAZyme-enriched target regulon. Inducible SiROCX overexpression selectively activated motif-containing CAZyme genes and markedly enhanced xylanase and cellulase activities on xylan and native barley root cell walls. Premature activation of this program triggered expression of a plant immune marker despite comparable fungal biomass, indicating that precise temporal control of CAZyme deployment is required to maintain symbiotic compatibility. Together, these findings identify SiROCX as a central regulator of a monocot-adapted cell wall-degrading secretome and reveal a basidiomycete-specific regulatory module that coordinates host cell wall remodeling with immune-compatible symbiotic colonization. SignificanceBeneficial fungi colonize living plant cells, requiring host cell wall remodeling while avoiding immune activation. However, the key transcriptional regulators coordinating this process in basidiomycetes during symbiotic root colonization remain unknown. We identify SiROCX, a conserved basidiomycete-specific transcription factor, as a master activator of a monocot-adapted xylan/cellulose degradation program in the root endophyte Serendipita indica. By integrating in planta co-expression networks, DAP-seq, secretome proteomics, and enzymatic assays, we show that SiROCX overexpression markedly enhances secretion and activity of xylan- and cellulose-degrading enzymes, boosting sugar release from monocot cell walls. These findings reveal a basidiomycete-specific regulatory module for immune-compatible host cell wall remodeling, providing a framework to engineer fungal CAZyme programs for crop symbiosis and biomass conversion.

microbiology↗

A combination of the geroprotectors trametinib and rapamycin is more effective than either drug alone

Genetic suppression of activity of the insulin/IGF/mTORC1/Ras network can ameliorate the effects of ageing in animals. The network provides multiple drug targets because of its role in metabolic disease and cancer, and these are candidates for repurposing for geroprotection. For instance, inhibition of the activity of the mTORC1 complex by rapamycin can extend lifespan in multiple organisms including mice, with early indications of efficacy in humans. Trametinib inhibits MEKs in the Ras pathway and can extend lifespan in Drosophila. However, it is not yet known if trametinib alone or in combination with rapamycin can extend mouse lifespan or improve health at older ages. We assessed survival and health indices of female and male mice treated with trametinib or rapamycin alone, or with the two in combination at the same doses. Trametinib treatment extended lifespan in both sexes, while its combination with rapamycin caused further, additive prolongation. Combination treatment reduced liver tumours in both sexes and spleen tumours in males, and ameliorated the age-related increase in brain glucose uptake. There was a striking reduction in inflammation in the brain, kidney, spleen and muscle with combination treatment, accompanied by reduced circulating levels of pro-inflammatory cytokines. Trametinib alone is therefore geroprotective in mice, but combined trametinib and rapamycin treatment is more geroprotective than treatment with either drug alone, suggesting immediate translational potential for humans.

physiology↗